Bradley Glover
Directeur des opérations chez IMUGENE LIMITED
Fortune : 109 220 $ au 31/05/2024
Postes actifs de Bradley Glover
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| IMUGENE LIMITED | Directeur des opérations | 21/08/2023 | - |
Historique de carrière de Bradley Glover
Anciens postes connus de Bradley Glover
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CELULARITY INC. | Directeur des opérations | 04/10/2022 | 31/05/2023 |
| Directeur Technique/Scientifique/R&D | 16/07/2021 | 04/10/2022 | |
Celularity, Inc. (United States)
 Celularity, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Celularity, Inc. engages in biotechnology company. The firm focuses on the study of placenta. The company was founded in Robert Joseph Hariri Gordon and Peter H. Diamandis in 2016 and is headquartered in Florham Park, NJ. | Directeur Technique/Scientifique/R&D | 01/03/2021 | - |
| KITE PHARMA INC | Corporate Officer/Principal | 01/09/2016 | - |
Formation de Bradley Glover
| The University of Colorado | Doctorate Degree |
| Rady School of Management at UC San Diego | Masters Business Admin |
| University of California San Diego | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
| Australie | 2 |
Opérationnelle
| Chief Operating Officer | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Consumer Services | 4 |
| Commercial Services | 3 |
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CELULARITY INC. | Commercial Services |
| IMUGENE LIMITED | Health Technology |
| Entreprise privées | 2 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
Celularity, Inc. (United States)
Celularity, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Celularity, Inc. engages in biotechnology company. The firm focuses on the study of placenta. The company was founded in Robert Joseph Hariri Gordon and Peter H. Diamandis in 2016 and is headquartered in Florham Park, NJ. | Commercial Services |
- Bourse
- Insiders
- Bradley Glover
- Expérience
